There are 700 resources available
124P - Acquired resistance to first-line chemo- and EGFRab-therapy in mCRC: Biopsy analysis of the iSCORE trial
Presenter: Rosemary Lane
Session: Poster Display session
125P - Circulating tumour DNA (ctDNA) as a prognostic biomarker in patients (pts) with refractory metastatic colorectal cancer (mCRC) receiving TAS102 with or without bevacizumab
Presenter: Nadia Saoudi Gonzalez
Session: Poster Display session
126P - The prognostic role and clinical association of CD20+B cells in colorectal cancer and liver metastasis
Presenter: wenjing Ye
Session: Poster Display session
128P - Real-world survival outcomes in MSS colorectal cancer(CRC) patients based on mesothelin(MSLN) expression
Presenter: Midhun Malla
Session: Poster Display session
129P - Clinical and molecular landscape of deficient mismatch repair (dMMR) colon cancer (CC) patients: Data from a large consecutive single-center cohort
Presenter: MIchela Bartolini
Session: Poster Display session
130P - Oxaliplatin immune-induced syndrome (OIIS): A potentially life-threatening complication in colorectal cancer (CRC) patients (pts)
Presenter: PAULA VAZQUEZ
Session: Poster Display session
131P - Machine learning-aided colorectal cancer detection based on circulating tumor cells
Presenter: Ana Paz
Session: Poster Display session
132P - Molecular characteristics of early-onset compared with late-onset colorectal cancer: A retrospective case controlled study
Presenter: Junwei Tang
Session: Poster Display session
133P - The role of determining the diagnostic value of circulating tumor DNA (ctDNA) and natural blood killers (NK) in the diagnosis of precancerous diseases of the colon and colorectal cancer (CRC)
Presenter: Innara Turkpenova
Session: Poster Display session
134P - Rate and clinical implications of uncommon KRAS mutations in colorectal cancer
Presenter: Lorenzo Gervaso
Session: Poster Display session